General Commentary ARTICLE
An expression of concern on
Discoidin Domain Receptors: Potential Actors and Targets in Cancer
by Rammal. H., Saby. C., Magnien. K., Van-Gulick. L., Garnotel, R., Buache, E., et al. (2016). Front. Pharmacol. 7:55. doi: 10.3389/fphar.2016.00055
With this notice, Frontiers states its awareness of concerns regarding a number of instances of failure to adequately cite or attribute credit appropriately within the above-referenced article. Prof. Theophile Godfraind and Prof. Olivier Feron, Chief Editors of the journal and specialty section respectively, will direct an investigation in full accordance with our procedures. The situation will be updated as soon as the investigation is complete.
UPDATE: This article has now been corrected. Please find the full correction here: https://doi.org/10.3389/fphar.2016.00346
Citation: Frontiers Editorial Office (2016) Expression of Concern: Discoidin Domain Receptors: Potential Actors and Targets in Cancer. Front. Pharmacol. 7:228. doi: 10.3389/fphar.2016.00228
Received: 14 July 2016; Accepted: 14 July 2016;
Published: 21 July 2016.
Edited and reviewed by: Théophile Godfraind, Université catholique de Louvain, Belgium
Copyright © 2016 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, firstname.lastname@example.org